Results 131 to 140 of about 299,280 (207)

Estimated Yield of Screening for Heterozygous Familial Hypercholesterolemia With and Without Genetic Testing in US Adults. [PDF]

J Am Heart Assoc, 2022
Bellows BK, Khera AV, Zhang Y, Ruiz-Negrón N, Stoddard HM, Wong JB, Kazi DS, de Ferranti SD, Moran AE.   +8 more
europepmc   +1 more source

Comparison of Clinical Characterization and Therapeutic Strategies between Homozygous Familial Hypercholesterolemia and Heterozygous Familial Hypercholesterolemia. [PDF]

J Atheroscler Thromb
Shishikura D, Harada-Shiba M, Michikura M, Sakaguchi K, Kusumoto H, Fujioka S, Fujisaka T, Kanzaki Y, Morita H.   +8 more
europepmc   +1 more source

Real-world lipid outcomes after switching PCSK9-targeting therapies in heterozygous familial hypercholesterolemia: the SHIFT-FH study. [PDF]

Intern Emerg Med
Calcaterra IL, De Luca C, Valletta LJ, D'Errico G, Ferrandino M, Cardiero G, Di Taranto MD, Fortunato G, Iannuzzo G, Tufano A, Di Minno M.   +10 more
europepmc   +1 more source

Myocardial strain impairment, heterozygous familial hypercholesterolemia and systemic arterial hypertension: Is there a link? [PDF]

Int J Cardiol Hypertens, 2021
Vitarelli A.
europepmc   +1 more source

Optimized Treatment of Refractory Hypercholesterolemia in Patients With Atherosclerotic Cardiovascular Disease or Heterozygous Familial Hypercholesterolemia With Alirocumab (OPTIMIZE). [PDF]

Front Cardiovasc Med, 2022
Sudano I, Mach F, Moccetti T, Burkard T, Fahe C, Delabays A, Rickli H, Keller PF, Dopheide J, Bodenmann S, Fiolka T, Ehret G, Spirk D.   +12 more
europepmc   +1 more source

Real-World Experience from Türkiye: Genetic and Therapeutic Insights in Pediatric Heterozygous Familial Hypercholesterolemia [PDF]

J Clin Res Pediatr Endocrinol
Yazıcı H, Er E, Erdem F, Yüksel Yanbolu A, Mammadova S, Alpdoğan S, Yoldaş Çelik M, Atik Altınok Y, Canda E, Aykut A, Akın H, Kalkan Uçar S, Çoker M.   +12 more
europepmc   +1 more source

Cascade Screening and Treatment Initiation in Young Adults with Heterozygous Familial Hypercholesterolemia. [PDF]

J Clin Med, 2021
Peterson AL, Bang M, Block RC, Wong ND, Karalis DG.   +4 more
europepmc   +1 more source

Diagnostic and Therapeutic Challenges of Homozygous and Severe Heterozygous Familial Hypercholesterolemia from Clinical Aspect-A Single-Center Study. [PDF]

J Clin Med
Nádró B, Kaluha J, Lőrincz H, Varga É, Balogh I, Harangi M.   +5 more
europepmc   +1 more source

Efficacy and safety of tafolecimab in Chinese patients with heterozygous familial hypercholesterolemia: a randomized, double-blind, placebo-controlled phase 3 trial (CREDIT-2). [PDF]

BMC Med, 2023
Chai M, He Y, Zhao W, Han X, Zhao G, Ma X, Qiao P, Shi D, Liu Y, Han W, An P, Li H, Yan S, Ma Q, Deng H, Qian L, Zhou Y, CREDIT-2 investigators.   +17 more
europepmc   +1 more source

Cataract Surgery in Elderly Subjects with Heterozygous Familial Hypercholesterolemia in Prolonged Treatment with Statins. [PDF]

J Clin Med, 2021
Marco-Benedí V, Laclaustra M, Sánchez-Hernández RM, Ortega-Martínez de Victoria E, Pedro-Botet J, Puzo J, Civeira F.   +6 more
europepmc   +1 more source